Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro
- 28 February 2012
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 153 (5) , 2088-2098
Abstract
We investigate the role of protein kinase C (PKC) in the control of medullary thyroid carcinoma (MTC) cell proliferation by a PKC inhibitor, Enzastaurin, in human MTC primary cultures and in the TT cell line. We found that PKC inhibition reduces cell proliferation by inducing caspase-mediated apoptosis and blocks the stimulatory effect of IGF-I on calcitonin secretion. Enzastaurin reduces PKCβII (Thr500) phosphorylation, indicating a direct involvement of this isoform as well as the phosphorylated levels of Akt (Ser 473) and glycogen synthase kinase (Ser9), PKC pathway downstream targets and pharmacodynamic markers for PKC inhibition. PKCβII and PKCδ enzyme isoforms expression and localization were investigated. These data indicate that in vitro PKC is involved in the control of human MTC proliferation and survival by modulating apoptosis, with a mechanism that implicates PKCβII inhibition and translocation in different subcellular compartments. Targeting PKC may represent a useful therapeutic approach for controlling MTC proliferation.Keywords
This publication has 43 references indexed in Scilit:
- Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumorsEndocrine-Related Cancer, 2011
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid CancerJournal of Clinical Oncology, 2009
- Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targetsJournal of Molecular Endocrinology, 2009
- The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT PathwayJournal of Investigative Dermatology, 2006
- Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell linesMolecular Cancer Therapeutics, 2006
- Rapid Association of Protein Kinase C-ϵ with Insulin Granules Is Essential for Insulin ExocytosisJournal of Biological Chemistry, 2003
- Stimulatory Effect of Insulin on Calcitonin SecretionHormone and Metabolic Research, 1998
- Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell linesCancer Genetics and Cytogenetics, 1995
- An isoform of the human calcitonin receptor is expressed in TT cells and in medullary carcinoma of the thyroidFEBS Letters, 1994